BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3305037)

  • 1. Toleration and safety of piroxicam.
    Heynen G
    Eur J Rheumatol Inflamm; 1987; 8(1):86-93. PubMed ID: 3305037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piroxicam in acute musculoskeletal disorders and sport injuries.
    Heere LP
    Eur J Rheumatol Inflamm; 1987; 8(1):60-4. PubMed ID: 3305036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piroxicam pharmacokinetics: recent clinical results relating kinetics and plasma levels to age, sex, and adverse effects.
    Hobbs DC
    Am J Med; 1986 Nov; 81(5B):22-8. PubMed ID: 3538867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical evaluation of piroxicam gel: an open comparative trial with diclofenac gel in the treatment of acute musculoskeletal disorders.
    Kroll MP; Wiseman RL; Guttadauria M
    Clin Ther; 1989; 11(3):382-91. PubMed ID: 2663165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term evaluation of the treatment of osteoarthritis.
    Zizic TM; Sutton JD; Stevens MB
    Am J Med; 1986 Nov; 81(5B):29-35. PubMed ID: 3538868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of piroxicam and ibuprofen in rheumatoid arthritis.
    Alam MN; Kabir MZ
    Bangladesh Med Res Counc Bull; 1983 Dec; 9(2):54-9. PubMed ID: 6609700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind evaluation of piroxicam and indomethacin in the treatment of inflammation following oral surgery.
    Ohnishi M; Kawai T; Ogawa N
    Eur J Rheumatol Inflamm; 1983; 6(3):259-65. PubMed ID: 6391930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind evaluation of piroxicam and naproxen following missed dosage in patients with inflammatory arthritis.
    Langley GB; Fowles M; Sirett P; Vlieg M; Wigley RD
    N Z Med J; 1985 Jun; 98(781):490-2. PubMed ID: 3892383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre double-blind comparison of piroxicam and indomethacin in the treatment of lumbar diseases.
    Aoki T; Kuroki Y; Kageyama T; Irimajiri S; Mizushima Y; Yamamoto K
    Eur J Rheumatol Inflamm; 1983; 6(3):247-52. PubMed ID: 6239779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of nonsteroidal anti-inflammatory drug pharmacokinetics.
    Brune K
    Eur J Rheumatol Inflamm; 1987; 8(1):18-23. PubMed ID: 3622591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of piroxicam revisited. A global meta-analysis of randomised clinical trials.
    Richy F; Scarpignato C; Lanas A; Reginster JY
    Pharmacol Res; 2009 Oct; 60(4):254-63. PubMed ID: 19467328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drugs: assessment of risks.
    Inman WH
    Eur J Rheumatol Inflamm; 1987; 8(1):71-85. PubMed ID: 2957207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piroxicam and gastrointestinal bleeding.
    Giercksky KE
    Am J Med; 1986 Nov; 81(5B):2-5. PubMed ID: 3491541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
    Ravaud P; Auleley GR; Ayral X; Marre JP; Amor B
    J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study.
    Jick H; Derby LE; García Rodríguez LA; Jick SS; Dean AD
    Pharmacotherapy; 1993; 13(3):212-7. PubMed ID: 8321735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Norwegian multicenter study.
    Husby G
    Am J Med; 1986 Nov; 81(5B):6-10. PubMed ID: 3538870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.